Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
Construction of the plant will commence in 2025 with first production expected to be in 2027
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
Akums Drugs will undertake this development and commercialization in India
The Notes shall not be offered or sold in India
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
The acquisition is based on an enterprise value of Rs. 1,660 crore
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
Subscribe To Our Newsletter & Stay Updated
